Addiction treatment and therapy is a multifaceted process that incorporates various therapeutic modalities, each designed to address different aspects of substance abuse and behavioural dependencies. Among these, cognitive-behavioural therapy (CBT) and dialectical behaviour therapy (DBT) stand out, providing individuals with a safe and supportive environment to explore the underlying factors contributing to their addictive behaviours. Through these therapies, individuals not only gain insight into their triggers and cravings but also acquire invaluable coping mechanisms and problem-solving skills to effectively manage them. Furthermore, addiction treatment extends beyond therapy alone, encompassing pharmacological interventions such as medication-assisted treatment (MAT) and detoxification services. MAT helps alleviate withdrawal symptoms and cravings while stabilizing brain chemistry, making the initial phases of recovery more manageable and safer for individuals. Detoxification services provide essential medical support during this critical period, ensuring the physical well-being and comfort of those undergoing withdrawal. Moreover, on-going support plays a crucial role in maintaining sobriety and navigating the challenges of everyday life post-treatment. Support groups, peer mentoring programs, and aftercare services offer individuals a sense of community and accountability, providing encouragement and guidance as they transition back into society. Family therapy is also integral to the recovery process, addressing the dynamics of familial relationships impacted by addiction and fostering healing and reconciliation among loved ones. In essence, addiction treatment represents a comprehensive framework that integrates therapeutic interventions, medical support, and holistic modalities to address the multifaceted nature of addiction. By empowering individuals to embark on a journey of self-discovery, healing, and transformation, treatment enables them to reclaim control of their lives, forge meaningful connections, and embrace a future defined by sobriety, resilience, and hope.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom